AB 2302: Food safety: infant formula.

Official summary

Legislative Counsel’s Digest (official, as of the latest version). Written by nonpartisan legislative staff; reproduced verbatim.

Existing law, the Sherman Food, Drug, and Cosmetic Law, provides for the regulation of various subjects relating to the manufacturing, processing, labeling, advertising, and sale of food, drugs, and cosmetics, under the administration and enforcement of the State Department of Public Health. A violation of these provisions is punishable as a misdemeanor.

This bill would require a manufacturer of infant formula for sale or distribution in this state to test its final infant formula product for arsenic, cadmium, lead, and mercury at least once per month. The bill also would, commencing on January 1, 2028, require a brand owner, as defined, to provide information to consumers on its internet website or package label regarding specific information about its infant formula that includes, among other things, certain test results for arsenic, cadmium, lead, and mercury. The bill would specifically prohibit a person from selling in the state or manufacturing, delivering, holding, or offering for sale in the state any infant formula that does not comply with these requirements. The bill would require the manufacturer and brand owner to provide test results to the department upon request, as specified.

By expanding the requirements relating to infant formula under the Sherman Food, Drug, and Cosmetic Law, the violation of which would be a crime, this bill would impose a state-mandated local program.

The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.

This bill would provide that no reimbursement is required by this act for a specified reason.

Sponsors

Sponsors by party (alphabetical): Democratic 4

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

1. July 1, 2026In committee: Set, first hearing. Hearing canceled at the request of author.
2. June 25, 2026From committee: Do pass and re-refer to Com. on E.Q. (Ayes 9. Noes 0.) (June 24). Re-referred to Com. on E.Q.
3. June 15, 2026From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on HEALTH.
4. June 10, 2026Referred to Coms. on HEALTH and E.Q.
5. May 28, 2026In Senate. Read first time. To Com. on RLS. for assignment.
6. May 27, 2026Read third time. Passed. Ordered to the Senate. (Ayes 69. Noes 0. Page 5481.)
7. May 19, 2026Read second time. Ordered to third reading.
8. May 18, 2026Read second time and amended. Ordered returned to second reading.
9. May 14, 2026From committee: Amend, and do pass as amended. (Ayes 12. Noes 0.) (May 14).
10. May 14, 2026Joint Rule 62(a), file notice suspended. (Page 5030.)
11. May 13, 2026In committee: Set, first hearing. Referred to APPR. suspense file.
12. April 20, 2026Re-referred to Com. on APPR.